- €38.45bn
- €74.06bn
- €82.57bn
- 37
- 92
- 83
- 84
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 60,058 | 44,306 | 57,866 | 93,865 | 82,565 |
Cost of Revenue | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 56,382 | 42,764 | 51,144 | 92,683 | 76,459 |
Operating Profit | 3,676 | 1,542 | 6,722 | 1,182 | 6,106 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,289 | -77 | 5,372 | -1,876 | 3,935 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,649 | -743 | 3,677 | -1,793 | 2,904 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 985 | -1,538 | 3,660 | 217 | 2,209 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 820 | -1,725 | 3,539 | 140 | 2,024 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.821 | 0.16 | 1.49 | 0.281 | 2.77 |
Dividends per Share |